The expression of ZNF382 was significantly lower in the pediatric AML samples compared with the control samples, and patients with ZNF382 methylation had lower ZNF382 transcript levels compared to the patients with no ZNF382 methylation. Here, ZNF382 is linked to acute myeloid leukemia.